Induction/NN
of/IN
cytokine/NN
expression/NN
in/IN
leukocytes/NNS
by/IN
binding/NN
of/IN
thrombin-stimulated/JJ
platelets/NNS
./.

BACKGROUND/NN
:/:
Activated/VBN
platelets/NNS
tether/VBP
and/CC
activate/VBP
myeloid/JJ
leukocytes/NNS
./.
=====
To/TO
investigate/VB
the/DT
potential/JJ
relevance/NN
of/IN
this/DT
mechanism/NN
in/IN
acute/JJ
myocardial/JJ
infarction/NN
(/(
AMI/NN
)/)
,/,
we/PRP
examined/VBD
cytokine/NN
induction/NN
by/IN
leukocyte-platelet/JJ
adhesion/NN
and/CC
the/DT
occurrence/NN
of/IN
leukocyte-platelet/JJ
conjugates/NNS
in/IN
patients/NNS
with/IN
AMI/NN
./.
=====
METHODS/NNS
AND/CC
RESULTS/NNS
:/:
We/PRP
obtained/VBD
peripheral/JJ
venous/JJ
blood/NN
samples/NNS
in/IN
20/CD
patients/NNS
with/IN
AMI/NN
before/IN
and/CC
daily/RB
for/IN
5/CD
days/NNS
after/IN
direct/JJ
percutaneous/JJ
transluminal/JJ
coronary/JJ
angioplasty/NN
(/(
PTCA/NN
)/)
and/CC
in/IN
20/CD
patients/NNS
undergoing/VBG
elective/JJ
PTCA/NN
./.
=====
Throughout/IN
the/DT
study/NN
period/NN
,/,
CD41/NN
immunofluorescence/NN
of/IN
leukocytes/NNS
(/(
flow/NN
cytometry/NN
)/)
revealed/VBD
increased/VBN
leukocyte-platelet/JJ
adhesion/NN
in/IN
patients/NNS
with/IN
AMI/NN
compared/VBN
with/IN
control/JJ
patients/NNS
(/(
mean/NN
+/-/CC
SE/NN
of/IN
fluorescence/NN
[/(
channels/NNS
]/)
before/IN
PTCA/NN
:/:
77/CD
+/-/CC
16/CD
versus/CC
35/CD
+/-/CC
9/CD
;/:
P/NN
=/JJ
.003/CD
)/)
./.
=====
In/FW
vitro/FW
,/,
thrombin-stimulated/JJ
fixed/JJ
platelets/NNS
bound/VBD
to/TO
neutrophils/NNS
and/CC
monocytes/NNS
./.
=====
Within/IN
2/CD
hours/NNS
,/,
this/DT
resulted/VBD
in/IN
increased/VBN
mRNA/NN
for/IN
interleukin/NN
(/(
IL/NN
)/)
,/,
1/CD
beta/NN
,/,
IL-8/NN
,/,
and/CC
monocyte/NN
chemoattractant/NN
protein/NN
(/(
MCP/NN
)/)
-1/CD
in/IN
unfractionated/JJ
leukocytes/NNS
./.
=====
After/IN
4/CD
hours/NNS
,/,
IL-1/NN
beta/NN
and/CC
IL-8/NN
concentration/NN
of/IN
the/DT
cell-free/JJ
supernatant/NN
had/VBD
increased/VBN
by/IN
268/CD
+/-/CC
36/CD
%/NN
and/CC
210/CD
+/-/CC
7/CD
%/NN
,/,
respectively/RB
,/,
and/CC
cellular/JJ
MCP-1/NN
content/NN
had/VBD
increased/VBN
by/IN
170/CD
+/-/CC
8/CD
%/NN
./.
=====
Addition/NN
of/IN
activated/VBN
platelets/NNS
to/TO
adherent/JJ
monocytes/NNS
had/VBD
a/DT
similar/JJ
effect/NN
and/CC
was/VBD
associated/VBN
with/IN
nuclear/JJ
factor-kappa/NN
B/NN
activation/NN
./.
=====
Inhibition/NN
of/IN
binding/NN
by/IN
anti-P/JJ
selectin/NN
antibodies/NNS
reduced/VBD
the/DT
effect/NN
of/IN
activated/VBN
platelets/NNS
on/IN
cytokine/NN
production/NN
./.
=====
CONCLUSIONS/NNS
:/:
In/IN
patients/NNS
with/IN
AMI/NN
,/,
leukocyte-platelet/JJ
adhesion/NN
is/VBZ
increased/VBN
./.
=====
Binding/NN
of/IN
activated/VBN
platelets/NNS
induces/VBZ
IL-1/NN
beta/NN
,/,
IL-8/NN
,/,
and/CC
MCP-1/NN
in/IN
leukocytes/NNS
./.
=====
Our/PRP$
findings/NNS
suggest/VBP
that/IN
leukocyte-platelet/JJ
adhesion/NN
contributes/VBZ
to/TO
the/DT
regulation/NN
of/IN
inflammatory/JJ
responses/NNS
in/IN
AMI/NN
./.